Results 241 to 250 of about 225,025 (354)

Evaluating Bacillus Calmette-Guérin Polysaccharide Nucleic Acid as an Adjuvant for Influenza Vaccines in Mice. [PDF]

Influenza Other Respir Viruses
Yan S, Yang F, Ji J, Lin X, Wang P, Wu H, Cheng L, Liu F, Wu N, Yao H, Wu WSJ, Wu H.   +11 more
europepmc   +1 more source

Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity

, 2018
Yasuko Hatta, David A. Boltz, Sally R. Sarawar, Yoshihiro Kawaoka, Gabriele Neumann, Pamuk Bilsel   +5 more
openalex   +1 more source

Molecular detection of pathogens in an equine fever diagnostic panel: 2019–2023

Equine Veterinary Journal, EarlyView.
Abstract Background A common diagnostic approach for febrile horses is to test for a panel of potential pathogens. Panels are curated by expert opinion and vary between diagnostic laboratories. Objectives To report the results of a newly developed equine fever diagnostic panel (EFDP) between 2019 and 2023 and evaluate the frequency of positive results.
Toby L. Pinn‐Woodcock, Melissa S. Aprea, Manigandan Lejeune, Joy E. Tomlinson   +3 more
wiley   +1 more source

Multivalent COBRA Hemagglutinin and Neuraminidase Influenza Vaccines Adjuvanted with TLR9 Agonist CpG 1018. [PDF]

Vaccines (Basel)
Sanchez PL, Lynch A, Ross TM.
europepmc   +1 more source

Newly identified properties of known pharmaceuticals and myxobacterial small molecules revealed by screening for autophagy modulators

The FEBS Journal, EarlyView.
Autophagy is a cellular degradation process involved in, for example, immune responses to pathogens and neurodegeneration. To identify modulators of autophagy, we developed a microscopy‐based screening assay and identified previously unknown autophagy‐modulating activities in known drugs and natural products from myxobacteria and fungi.
Janine Fichtner, Yan Yan Beer, H. G. Mauricio Ramm, Sabrina Mühlen, Frank Surup, Jennifer Herrmann, Toni Luise Meister, Stephanie Pfaender, Ursula Bilitewski, Mark Brönstrup, Rolf Müller, Manfred Wirth, Eeva‐Liisa Eskelinen, Ingo Schmitz   +13 more
wiley   +1 more source

Estimated Relative Effectiveness and Public Health Impact of Cell-Based Versus Egg-Based Influenza Vaccines During the 2022-2023 Season in the United States. [PDF]

Influenza Other Respir Viruses
Stein AN, Thanataveerat A, McDermott KW, Dean A, Wall S, Pack C, Sullivan SG, McGovern I, Haag MDM.   +8 more
europepmc   +1 more source

Understanding the Epidemiology of Pertussis in Denmark

Acta Paediatrica, EarlyView.
Tine Dalby, Aoife Ronayne, Peter Henrik Andersen   +2 more
wiley   +1 more source

Lung organoids as a human system for Mycobacteria infection modeling and drug testing

The FEBS Journal, EarlyView.
Mycobacterial infections, including tuberculosis (TB) and infections by nontuberculous mycobacteria (NTM), are still public health issues. In 2023, TB caused 1.25 million deaths, while NTM remain a clinical challenge for patients with cystic fibrosis (CF).
Stephen Adonai Leon‐Icaza, Romain Vergé, Raoul Mazars, Laurence Berry, Céline Cougoule   +4 more
wiley   +1 more source

Relative Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccines in Preventing Hospitalizations: A National Retrospective Cohort Study in France, 2022/2023 Season. [PDF]

Influenza Other Respir Viruses
Bricout H, Levant MC, Crépey P, Gavazzi G, Gaillat J, Dufournet M, Assi N, Grenier B, Raguideau F, Péretz F, Salamand C, Mosnier A, Watier L, Launay O, Loiacono MM.   +14 more
europepmc   +1 more source

Effective communication and public engagement strategies to counter misinformation about infectious diseases

Immunology &Cell Biology, EarlyView.
Public trust and cooperation in infectious disease control rest on three pillars: engagement, vaccine communication, and data presentation. Together, these foundations support resilient and inclusive public health responses to misinformation and uncertainty.
Sheena Cruickshank, Martin McKee, Christina Pagel   +2 more
wiley   +1 more source